Abstract
Summary
Preparations from human breast tumors which are inactive in the formation of steroid sulfates are shown to be lacking the two sulfate-activating enzymes, sulfate adenylyltransferase, and adenylylsulfate kinase, and to have measurable amounts of 3-β-hydroxysteroid sulfotransferase and estrone sulfotransferase. The study also suggests that the sulfate-activating enzymes are the limiting factor in determining the level of steroid conjugating activity of the tumor preparations that have the ability to form steroid sulfates.
Get full access to this article
View all access options for this article.
